COLRF(COLRF)
COLRF
10/7/26
Tian An Medicare (COLRF)
Wednesday
12:41 AM
ThesisThe company is positioning itself for growth through strategic partnerships and cost management initiatives, which could enhance profitability in the medium term.
Revenue Outlook
What’s Driving the Stock
- 01Recent partnerships with local governments to enhance healthcare access could drive patient volume growth by 15% YoY.
- 02Implementation of cost control measures has led to a projected 10% reduction in operating expenses over the next fiscal year.
- 03Expansion into underserved rural areas could unlock new revenue streams, potentially increasing overall revenue by 20% over the next two years.
- 04Aging population driving demand for healthcare services
- 05Increased focus on healthcare accessibility in rural areas
- 06Changes in healthcare regulations affecting reimbursement rates
- 07Patient volume growth in urban centers
- 08Partnerships with government health programs
FY2025 Snapshot
- Revenue
- $1.7B
- Rev. Growth
- +3.8%
- Gross Margin
- 10.3%
- Op. Margin
- 5.3%
- Net Margin
- -1.6%
- Net Income
- $-27M
- NI Growth
- -193%
- EPS
- $-0.02
- 1Y Return
- +0.0%
COLRF Chart
My Notes
- "We are committed to expanding our reach and improving operational efficiency to better serve our patients."
- Moat: The company's established network and partnerships provide a moderate level of competitive advantage…
- value - Investors may be drawn to the low valuation metrics, particularly the price-to-sales ratio of 0.5x.
- Rising interest rates could increase financing costs for expansion projects, potentially impacting capital expenditures and overall…
- Watch on earnings: Occupancy rates of healthcare facilities, Regulatory changes in healthcare reimbursement policies, Growth in patient volumes.
One Sentence Summary:
Tian An Medicare: the setup is constructive — recent partnerships with local governments to enhance healthcare access could drive patient volume growth by 15% yoy.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
Explore More
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers